Education
About Us
Working with TipRanks
Follow Us
Curaleaf Holdings (TSE:CURA)
TSX:CURA
CURA Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.99 - C$5.00
Previous CloseN/A
Volume356.48K
Average Volume (3M)990.75K
Market Cap
$3.04B
Enterprise ValueC$2.26B
Total Cash (Recent Filing)$102.27M
Total Debt (Recent Filing)$843.02M
Price to Earnings (P/E)―
Beta2.19
Next Earnings
Nov 10, 2025EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding670,458,400
10 Day Avg. Volume989,180
30 Day Avg. Volume990,747
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.74
Enterprise Value/Revenue1.76
Enterprise Value/Gross Profit3.61
Enterprise Value/Ebitda10.27
Forecast
1Y Price Target
$4.51Price Target Upside10.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Market ExpansionExpansion into new markets is anticipated to increase revenue streams.
Operational EfficiencyOperational efficiencies are expected to drive margins.
Sales GrowthSales growth in 2Q24 was largely driven by wholesale revenue growth as the international segment continues to gain traction.
Bears Say
CompetitionThe company is facing stiff competition in the cannabis industry.
Financial PerformanceEBITDA margins fell short of expectations due to higher G&A spend and heavy promotions at the start of the quarter.
Regulatory ChallengesThere are concerns about regulatory challenges in the cannabis market.
Curaleaf Holdings News
CURA FAQ
What was Curaleaf Holdings’s price range in the past 12 months?
Curaleaf Holdings lowest stock price was C$0.99 and its highest was C$5.00 in the past 12 months.
What is Curaleaf Holdings’s market cap?
Curaleaf Holdings’s market cap is $3.04B.
When is Curaleaf Holdings’s upcoming earnings report date?
Curaleaf Holdings’s upcoming earnings report date is Nov 10, 2025 which is in 61 days.
How were Curaleaf Holdings’s earnings last quarter?
Curaleaf Holdings released its earnings results on Aug 06, 2025. The company reported -C$0.083 earnings per share for the quarter, the consensus estimate of -C$0.083 by C$0.
Is Curaleaf Holdings overvalued?
According to Wall Street analysts Curaleaf Holdings’s price is currently Undervalued.
Does Curaleaf Holdings pay dividends?
Curaleaf Holdings does not currently pay dividends.
What is Curaleaf Holdings’s EPS estimate?
Curaleaf Holdings’s EPS estimate is -0.1.
How many shares outstanding does Curaleaf Holdings have?
Curaleaf Holdings has 670,458,400 shares outstanding.
What happened to Curaleaf Holdings’s price movement after its last earnings report?
Curaleaf Holdings reported an EPS of -C$0.083 in its last earnings report, expectations of -C$0.083. Following the earnings report the stock price went up 4.329%.
Which hedge fund is a major shareholder of Curaleaf Holdings?
Currently, no hedge funds are holding shares in TSE:CURA
Curaleaf Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.51 (10.53% Upside)
$4.51 (10.53% Upside)
Blogger Sentiment
Bullish
TSE:CURA Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $73.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 5.7%
Last 30 Days ▲ 5.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.25%
12-Months-Change
Fundamentals
Return on Equity
-24.93%
Trailing 12-Months
Asset Growth
-5.39%
Trailing 12-Months
Company Description
Curaleaf Holdings
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.
CURA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong international growth and product innovation as key positive aspects. However, domestic revenue challenges, margin pressures, and regulatory uncertainties present significant challenges. The call reflects a balanced outlook with robust international performance countered by domestic and regulatory pressures.View all TSE:CURA earnings summariesCURA Stock 12 Month Forecast
Average Price Target
C$4.51
▲(10.53% Upside)
Technical Analysis
Options Prices
Currently, No data available
---